STATE STREET CORP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2023$239,443,645
+58.0%
8,075,671
-15.5%
0.01%
+50.0%
Q3 2023$151,587,891
+1.2%
9,551,852
+20.3%
0.01%0.0%
Q2 2023$149,807,307
+128.5%
7,938,914
-53.5%
0.01%
+100.0%
Q1 2023$65,575,519
-62.2%
17,076,958
-51.2%
0.00%
-20.0%
Q4 2022$173,680,480
+149.0%
35,016,226
+139.9%
0.01%
+25.0%
Q3 2022$69,763,000
-14.8%
14,594,873
-19.8%
0.00%
-20.0%
Q2 2022$81,898,000
+25.5%
18,199,554
+32.8%
0.01%
+66.7%
Q1 2022$65,247,000
+9.0%
13,707,389
+69.9%
0.00%0.0%
Q4 2021$59,869,000
+16.5%
8,068,567
-11.0%
0.00%0.0%
Q3 2021$51,403,000
-27.2%
9,065,857
-15.4%
0.00%
-25.0%
Q2 2021$70,644,000
-3.3%
10,719,931
+18.8%
0.00%0.0%
Q1 2021$73,090,000
+28.7%
9,023,479
+2.5%
0.00%
+33.3%
Q4 2020$56,785,000
+76.0%
8,803,841
-1.8%
0.00%
+50.0%
Q3 2020$32,270,000
-23.6%
8,964,006
-2.4%
0.00%
-33.3%
Q2 2020$42,243,000
+116.4%
9,183,306
+60.4%
0.00%
+50.0%
Q1 2020$19,525,000
-28.5%
5,725,865
+7.1%
0.00%0.0%
Q4 2019$27,294,000
+81.6%
5,346,426
-13.9%
0.00%
+100.0%
Q3 2019$15,027,000
+134.5%
6,209,347
+110.3%
0.00%
Q2 2019$6,408,000
-81.3%
2,952,996
-76.7%
0.00%
-100.0%
Q1 2019$34,275,000
-11.8%
12,647,744
+56.1%
0.00%
-25.0%
Q4 2018$38,882,000
-54.0%
8,100,371
-9.3%
0.00%
-33.3%
Q3 2018$84,579,000
-3.4%
8,931,512
-0.7%
0.01%
-14.3%
Q2 2018$87,532,000
+15.0%
8,996,007
+24.3%
0.01%
+16.7%
Q1 2018$76,137,000
+42.3%
7,237,248
-13.3%
0.01%
+50.0%
Q4 2017$53,496,000
+13.2%
8,345,171
+35.1%
0.00%0.0%
Q3 2017$47,260,000
+60.5%
6,177,805
+49.2%
0.00%
+33.3%
Q2 2017$29,450,000
+376.2%
4,141,583
+159.1%
0.00%
+200.0%
Q1 2017$6,185,000
+98.6%
1,598,707
+4.7%
0.00%
Q4 2016$3,115,000
-21.5%
1,526,398
+3.1%
0.00%
Q3 2016$3,967,000
-57.6%
1,480,770
-51.3%
0.00%
-100.0%
Q2 2016$9,367,000
-57.3%
3,042,041
+18.1%
0.00%
-50.0%
Q1 2016$21,950,000
-38.3%
2,576,027
-1.7%
0.00%
-50.0%
Q4 2015$35,548,000
+14.8%
2,619,662
-18.8%
0.00%0.0%
Q3 2015$30,971,000
-34.1%
3,225,865
-1.3%
0.00%
-20.0%
Q2 2015$47,020,000
+24.2%
3,269,703
-22.7%
0.01%
+25.0%
Q1 2015$37,863,000
+97.6%
4,230,582
+34.7%
0.00%
+100.0%
Q4 2014$19,162,000
-35.7%
3,141,312
+11.6%
0.00%
-33.3%
Q3 2014$29,809,000
-0.8%
2,815,046
+11.0%
0.00%0.0%
Q2 2014$30,049,000
-22.9%
2,535,747
-2.9%
0.00%
-25.0%
Q1 2014$38,993,000
-41.5%
2,611,643
-46.1%
0.00%0.0%
Q4 2013$66,617,000
+48.5%
4,845,655
+83.9%
0.00%
-33.3%
Q3 2013$44,855,000
+4.1%
2,635,319
+1.4%
0.01%0.0%
Q2 2013$43,102,0002,598,2450.01%
Other shareholders
IMMUNOGEN INC shareholders Q2 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$310.00%
View complete list of IMMUNOGEN INC shareholders